Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...
EBR Systems said today that a new Medicare National Coverage Determination (NCD) will evaluate its leadless endocardial ...
CRT Innovation is the First to Offer Exclusive OptiVol® Fluid Status Monitoring with Complete Remote Follow-Up for Proactive Heart Failure Management “Atrial arrhythmias are the number one cause of ...
Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodeling compared to an implantable ...
2d
EBR Systems Secures National Coverage Determination Under TCET Pathway from CMS for the WiSE System
EBR Systems, Inc. (ASX: EBR), developer of the world’s only leadless left ventricular endocardial pacing (LVEP) system for ...
The European Society of Cardiology (ESC) Guidelines on cardiac pacing and cardiac resynchronization therapy (CRT) are published online today in European Heart Journal. The use of pacemakers continues ...
MINNEAPOLIS - Medtronic, Inc. today announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P. The Viva CRT-P is ...
Cardiac resynchronization therapy (CRT) has emerged as a cornerstone in the management of selected patients with chronic heart failure characterised by reduced left ventricular ejection fraction and ...
Today, the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Latin American Heart Rhythm Society (LAHRS) released a new clinical practice guideline on cardiac physiologic ...
Medtronic Inc announced the first United States implant of the InSync III Marquis implantable cardioverter-defibrillator (ICD) system and the start of a new clinical trial of the company's newest ...
Results from the Cardiac Resynchronization—Heart Failure (CARE-HF) study support the use of implantable cardiac-resynchronization devices in patients with heart failure due to left-ventricular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results